GABARAP emerges as a therapeutic target to prevent aminoglycoside-induced hearing loss
March 3, 2025
Aminoglycoside antibiotics are essential for treating some severe bacterial infections but are notorious for causing irreversible hearing loss in 20%-47% of patients.